Development and validation of an ultra-high performance liquid chromatography coupled to tandem mass spectrometry method for the quantification of the antileishmanial drug paromomycin in human skin tissue.

[1]  H. Rosing,et al.  Development and validation of a high-performance liquid chromatography tandem mass spectrometry method for the quantification of the antiparasitic and antifungal drug amphotericin B in human skin tissue. , 2022, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[2]  H. Rosing,et al.  Development and validation of an HPLC-MS/MS method for the quantification of the anti-leishmanial drug miltefosine in human skin tissue. , 2021, Journal of pharmaceutical and biomedical analysis.

[3]  H. Rosing,et al.  Skin tissue sample collection, sample homogenization, and analyte extraction strategies for liquid chromatographic mass spectrometry quantification of pharmaceutical compounds. , 2020, Journal of pharmaceutical and biomedical analysis.

[4]  H. Rosing,et al.  Highly sensitive UPLC-MS/MS method for the quantification of paromomycin in human plasma. , 2020, Journal of pharmaceutical and biomedical analysis.

[5]  M. Grogl,et al.  Topical paromomycin for New World cutaneous leishmaniasis , 2019, PLoS neglected tropical diseases.

[6]  H. Coles,et al.  Paromomycin , 2020, Reactions Weekly.

[7]  J. Schellens,et al.  Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs , 2017, Clinical Pharmacokinetics.

[8]  K. Dooley,et al.  Importance of Drug Pharmacokinetics at the Site of Action , 2017, Clinical and translational science.

[9]  E. Khalil,et al.  Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme , 2017, Clinical Drug Investigation.

[10]  R. Haque,et al.  Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh , 2015, PLoS neglected tropical diseases.

[11]  Faten Farouk,et al.  Challenges in the determination of aminoglycoside antibiotics, a review. , 2015, Analytica chimica acta.

[12]  F. Israel-Roming,et al.  Time and Temperature Stability of Collagenase Produced by Bacillus licheniformis , 2015 .

[13]  A. Nuñez,et al.  Rapid analysis of aminoglycoside antibiotics in bovine tissues using disposable pipette extraction and ultrahigh performance liquid chromatography-tandem mass spectrometry. , 2013, Journal of chromatography. A.

[14]  M. Grogl,et al.  Pharmacokinetics and Absorption of Paromomycin and Gentamicin from Topical Creams Used To Treat Cutaneous Leishmaniasis , 2013, Antimicrobial Agents and Chemotherapy.

[15]  D A Bohm,et al.  Validation of a method for the determination of aminoglycosides in different matrices and species based on an in-house concept , 2013, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.

[16]  Naidong Weng,et al.  Bioanalysis of drug in tissue: current status and challenges. , 2012, Bioanalysis.

[17]  A. Kaufmann,et al.  Determination of aminoglycoside residues by liquid chromatography and tandem mass spectrometry in a variety of matrices. , 2012, Analytica chimica acta.

[18]  S. Croft,et al.  Leishmaniasis chemotherapy--challenges and opportunities. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[19]  S. Sundar,et al.  Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial , 2011, The Lancet.

[20]  G. Kokwaro,et al.  Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study , 2010, PLoS neglected tropical diseases.

[21]  K. Róna,et al.  Determination of paromomycin residues in turkey tissues by liquid chromatography/mass spectrometry. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[22]  Shusheng Zhang,et al.  Simultaneous determination of 13 aminoglycoside residues in foods of animal origin by liquid chromatography-electrospray ionization tandem mass spectrometry with two consecutive solid-phase extraction steps. , 2008, Journal of chromatography. A.

[23]  S. Sundar,et al.  Paromomycin in the treatment of leishmaniasis , 2008, Expert opinion on investigational drugs.

[24]  R. Davidson,et al.  Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy. , 2007, The American journal of tropical medicine and hygiene.

[25]  Shyam Sundar,et al.  Injectable paromomycin for Visceral leishmaniasis in India. , 2007, The New England journal of medicine.

[26]  W. Kirch,et al.  Hydrophilic interaction chromatography combined with tandem-mass spectrometry to determine six aminoglycosides in serum. , 2004, Journal of chromatography. A.

[27]  R. Peto,et al.  Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran. , 2003, Bulletin of the World Health Organization.

[28]  T. Kanyok,et al.  Determination of paromomycin in human plasma and urine by reversed-phase high-performance liquid chromatography using 2,4-dinitrofluorobenzene derivatization. , 1997, Journal of chromatography. B, Biomedical sciences and applications.